| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 07, 2022 | Jun 08, 2022 | Agarwal Shefali Dir | Sell | Fate Therapeutics Inc | FATE | $21.89 | $18,409 | -31.37% |
| Jun 03, 2022 | Jun 08, 2022 | Agarwal Shefali Dir | Sell | Fate Therapeutics Inc | FATE | ~ | $0 | -0.00% |
| Jun 03, 2022 | Jun 06, 2022 | Agarwal Shefali Dir | Sell | Fate Therapeutics Inc | FATE | $22.8 | $18,400 | -30.10% |
| Feb 07, 2022 | Feb 09, 2022 | Agarwal Shefali | Sell | Epizyme, Inc. | EPZM | $1.5 | $1,587 | -0.67% |
| Feb 02, 2022 | Feb 04, 2022 | Agarwal Shefali | Sell | Epizyme, Inc. | EPZM | $1.37 | $3,615 | -1.65% |
| Jan 26, 2022 | Jan 28, 2022 | Agarwal Shefali | Sell | Epizyme, Inc. | EPZM | $2.02 | $5,902 | -1.79% |
| Dec 06, 2021 | Dec 08, 2021 | Agarwal Shefali | Sell | Epizyme, Inc. | EPZM | $2.93 | $5,215 | -1.08% |
| Feb 04, 2021 | Feb 05, 2021 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $11.21 | $10,862 | -0.92% |
| Jan 25, 2021 | Jan 28, 2021 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $11.41 | $32,770 | -3.65% |
| Dec 03, 2020 | Dec 07, 2020 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $13.54 | $34,148 | -3.21% |
| Jun 26, 2020 | Jun 30, 2020 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $16.15 | $29,151 | -2.24% |
| Mar 25, 2020 | Mar 27, 2020 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $15.28 | $18,993 | -1.70% |
| Jan 24, 2020 | Jan 28, 2020 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $22.17 | $99,169 | -7.07% |
| Jun 14, 2019 | Jun 17, 2019 | Agarwal Shefali Chief Medical Officer | Sell | Epizyme, Inc. | EPZM | $11.97 | $14,304 | -3.24% |